Concepts (245)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cerebral Hemorrhage | 7 | 2024 | 100 | 2.620 |
Why?
|
| Brain Diseases | 5 | 2020 | 76 | 1.590 |
Why?
|
| Subarachnoid Hemorrhage | 5 | 2024 | 110 | 1.510 |
Why?
|
| Intracranial Aneurysm | 5 | 2021 | 384 | 1.010 |
Why?
|
| Intracranial Hypotension | 3 | 2026 | 14 | 0.870 |
Why?
|
| Consciousness | 2 | 2023 | 12 | 0.870 |
Why?
|
| Cerebral Infarction | 1 | 2024 | 88 | 0.800 |
Why?
|
| Anticoagulants | 2 | 2018 | 529 | 0.780 |
Why?
|
| Critical Care | 4 | 2021 | 416 | 0.760 |
Why?
|
| Skilled Nursing Facilities | 1 | 2023 | 80 | 0.750 |
Why?
|
| Cholesterol | 1 | 2024 | 264 | 0.730 |
Why?
|
| Neurosurgical Procedures | 4 | 2018 | 105 | 0.680 |
Why?
|
| Coma | 3 | 2026 | 18 | 0.670 |
Why?
|
| Brain Death | 4 | 2022 | 15 | 0.670 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 3 | 2024 | 13 | 0.650 |
Why?
|
| Neurotoxicity Syndromes | 1 | 2020 | 23 | 0.640 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2020 | 11 | 0.630 |
Why?
|
| Blood Coagulation Disorders | 1 | 2020 | 23 | 0.620 |
Why?
|
| Stroke | 4 | 2022 | 1226 | 0.580 |
Why?
|
| Basilar Artery | 3 | 2021 | 34 | 0.580 |
Why?
|
| Brain Stem Infarctions | 2 | 2009 | 4 | 0.570 |
Why?
|
| Neurologists | 1 | 2018 | 7 | 0.550 |
Why?
|
| Hemorrhage | 2 | 2018 | 287 | 0.540 |
Why?
|
| Substance Withdrawal Syndrome | 2 | 2024 | 126 | 0.540 |
Why?
|
| Blood Coagulation Factors | 1 | 2018 | 16 | 0.530 |
Why?
|
| Plasma | 1 | 2018 | 39 | 0.530 |
Why?
|
| Humans | 46 | 2026 | 65872 | 0.520 |
Why?
|
| Brain Edema | 5 | 2012 | 29 | 0.510 |
Why?
|
| Infarction, Middle Cerebral Artery | 2 | 2016 | 99 | 0.500 |
Why?
|
| Warfarin | 1 | 2018 | 125 | 0.490 |
Why?
|
| Delayed Diagnosis | 1 | 2016 | 47 | 0.460 |
Why?
|
| Brain | 6 | 2017 | 1672 | 0.450 |
Why?
|
| Serotonin Syndrome | 1 | 2013 | 9 | 0.390 |
Why?
|
| Serotonin Antagonists | 1 | 2013 | 31 | 0.390 |
Why?
|
| Clozapine | 1 | 2013 | 32 | 0.390 |
Why?
|
| Citalopram | 1 | 2013 | 22 | 0.390 |
Why?
|
| Neurology | 1 | 2013 | 44 | 0.380 |
Why?
|
| Aged, 80 and over | 10 | 2018 | 5684 | 0.370 |
Why?
|
| Brain Ischemia | 2 | 2016 | 424 | 0.370 |
Why?
|
| Tomography, X-Ray Computed | 8 | 2013 | 1663 | 0.360 |
Why?
|
| Embolization, Therapeutic | 2 | 2021 | 339 | 0.360 |
Why?
|
| Magnetic Resonance Imaging | 12 | 2018 | 2325 | 0.360 |
Why?
|
| Registries | 1 | 2016 | 935 | 0.350 |
Why?
|
| Vasospasm, Intracranial | 1 | 2011 | 30 | 0.340 |
Why?
|
| Tegmentum Mesencephali | 2 | 2009 | 7 | 0.340 |
Why?
|
| Middle Aged | 15 | 2026 | 18518 | 0.340 |
Why?
|
| Persistent Vegetative State | 2 | 2010 | 2 | 0.320 |
Why?
|
| Hemodynamics | 1 | 2011 | 254 | 0.320 |
Why?
|
| Ischemic Attack, Transient | 1 | 2011 | 96 | 0.310 |
Why?
|
| Female | 23 | 2026 | 34459 | 0.310 |
Why?
|
| Myelinolysis, Central Pontine | 1 | 2009 | 2 | 0.300 |
Why?
|
| Anisocoria | 1 | 2009 | 3 | 0.300 |
Why?
|
| Benzodiazepines | 2 | 2024 | 107 | 0.290 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2009 | 27 | 0.290 |
Why?
|
| Quality of Health Care | 1 | 2013 | 535 | 0.290 |
Why?
|
| Hyperglycemia | 1 | 2009 | 109 | 0.280 |
Why?
|
| Pneumoperitoneum, Artificial | 1 | 2008 | 14 | 0.270 |
Why?
|
| Pupil Disorders | 1 | 2008 | 4 | 0.270 |
Why?
|
| Mediastinal Emphysema | 1 | 2008 | 12 | 0.270 |
Why?
|
| Pneumothorax | 1 | 2008 | 49 | 0.260 |
Why?
|
| Heart Arrest | 1 | 2010 | 177 | 0.260 |
Why?
|
| Aged | 11 | 2021 | 15155 | 0.250 |
Why?
|
| Biopsy | 1 | 2008 | 464 | 0.250 |
Why?
|
| Treatment Outcome | 9 | 2018 | 5832 | 0.250 |
Why?
|
| Fistula | 1 | 2026 | 17 | 0.240 |
Why?
|
| Male | 17 | 2021 | 31435 | 0.240 |
Why?
|
| Leukoencephalitis, Acute Hemorrhagic | 2 | 2020 | 3 | 0.240 |
Why?
|
| Retrospective Studies | 7 | 2022 | 6956 | 0.230 |
Why?
|
| Coronary Artery Bypass | 1 | 2008 | 292 | 0.230 |
Why?
|
| Guidelines as Topic | 2 | 2021 | 159 | 0.220 |
Why?
|
| Myocardial Infarction | 1 | 2011 | 922 | 0.200 |
Why?
|
| Time Factors | 3 | 2024 | 3780 | 0.200 |
Why?
|
| Coronary Artery Disease | 1 | 2008 | 326 | 0.200 |
Why?
|
| Adult | 11 | 2021 | 17595 | 0.180 |
Why?
|
| Neurologic Examination | 3 | 2011 | 54 | 0.180 |
Why?
|
| Cohort Studies | 4 | 2013 | 2653 | 0.180 |
Why?
|
| Central Nervous System Infections | 1 | 2021 | 9 | 0.170 |
Why?
|
| Hernia | 2 | 2012 | 14 | 0.170 |
Why?
|
| Movement Disorders | 1 | 2021 | 26 | 0.160 |
Why?
|
| Guideline Adherence | 1 | 2022 | 310 | 0.160 |
Why?
|
| Heart Transplantation | 1 | 2022 | 180 | 0.160 |
Why?
|
| Epstein-Barr Virus Infections | 1 | 2021 | 105 | 0.160 |
Why?
|
| Sodium | 2 | 2010 | 60 | 0.150 |
Why?
|
| Brain Stem | 2 | 2010 | 30 | 0.150 |
Why?
|
| Aneurysm, Ruptured | 2 | 2012 | 82 | 0.150 |
Why?
|
| Age Distribution | 2 | 2011 | 262 | 0.150 |
Why?
|
| Liver Transplantation | 1 | 2021 | 222 | 0.140 |
Why?
|
| Intensive Care Units | 2 | 2013 | 437 | 0.140 |
Why?
|
| Risk Factors | 4 | 2011 | 5477 | 0.140 |
Why?
|
| Hematoma, Subdural | 1 | 2018 | 10 | 0.140 |
Why?
|
| Betacoronavirus | 1 | 2020 | 182 | 0.130 |
Why?
|
| International Normalized Ratio | 1 | 2018 | 36 | 0.130 |
Why?
|
| Cerebrovascular Circulation | 2 | 2010 | 228 | 0.130 |
Why?
|
| Myelitis | 1 | 2017 | 4 | 0.130 |
Why?
|
| Meningoencephalitis | 1 | 2017 | 9 | 0.130 |
Why?
|
| Pharmaceutical Services | 1 | 2018 | 33 | 0.130 |
Why?
|
| Professional Role | 1 | 2018 | 45 | 0.130 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 206 | 0.130 |
Why?
|
| Zika Virus | 1 | 2017 | 38 | 0.130 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 39 | 0.120 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 220 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2011 | 1117 | 0.120 |
Why?
|
| Hematoma | 1 | 2017 | 85 | 0.120 |
Why?
|
| Pharmacists | 1 | 2018 | 131 | 0.120 |
Why?
|
| Computed Tomography Angiography | 1 | 2017 | 143 | 0.120 |
Why?
|
| Emergency Service, Hospital | 2 | 2016 | 1165 | 0.120 |
Why?
|
| Feasibility Studies | 1 | 2018 | 592 | 0.110 |
Why?
|
| Cerebral Angiography | 3 | 2012 | 303 | 0.110 |
Why?
|
| Reference Values | 2 | 2021 | 330 | 0.110 |
Why?
|
| Pandemics | 1 | 2020 | 691 | 0.110 |
Why?
|
| Patient Care Team | 1 | 2018 | 338 | 0.110 |
Why?
|
| Monitoring, Physiologic | 2 | 2013 | 170 | 0.110 |
Why?
|
| Seizures | 2 | 2012 | 141 | 0.100 |
Why?
|
| Acute Disease | 2 | 2021 | 665 | 0.100 |
Why?
|
| Hiccup | 1 | 2013 | 3 | 0.100 |
Why?
|
| Cyproheptadine | 1 | 2013 | 2 | 0.100 |
Why?
|
| Medulla Oblongata | 1 | 2013 | 7 | 0.100 |
Why?
|
| Eclampsia | 1 | 2012 | 3 | 0.090 |
Why?
|
| Pons | 2 | 2010 | 15 | 0.090 |
Why?
|
| Brain Infarction | 1 | 2012 | 21 | 0.090 |
Why?
|
| Central Nervous System Vascular Malformations | 1 | 2013 | 79 | 0.090 |
Why?
|
| Intra-Abdominal Hypertension | 1 | 2011 | 2 | 0.090 |
Why?
|
| Thalamus | 2 | 2010 | 78 | 0.090 |
Why?
|
| Epilepsy, Tonic-Clonic | 1 | 2011 | 8 | 0.090 |
Why?
|
| Dominance, Cerebral | 1 | 2011 | 32 | 0.090 |
Why?
|
| Intracranial Hypertension | 1 | 2011 | 9 | 0.090 |
Why?
|
| Paresis | 1 | 2011 | 15 | 0.090 |
Why?
|
| Pineal Gland | 1 | 2011 | 26 | 0.090 |
Why?
|
| Recovery of Function | 2 | 2013 | 293 | 0.090 |
Why?
|
| Multiple Trauma | 1 | 2011 | 31 | 0.090 |
Why?
|
| Laparotomy | 1 | 2011 | 56 | 0.090 |
Why?
|
| Regional Blood Flow | 1 | 2011 | 117 | 0.090 |
Why?
|
| Middle Cerebral Artery | 1 | 2011 | 53 | 0.080 |
Why?
|
| Decompression, Surgical | 1 | 2011 | 71 | 0.080 |
Why?
|
| Prognosis | 2 | 2022 | 1793 | 0.080 |
Why?
|
| Thrombolytic Therapy | 1 | 2012 | 205 | 0.080 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2011 | 172 | 0.080 |
Why?
|
| Isoflurane | 1 | 2010 | 17 | 0.080 |
Why?
|
| Sex Distribution | 1 | 2011 | 252 | 0.080 |
Why?
|
| Status Epilepticus | 1 | 2010 | 24 | 0.080 |
Why?
|
| Natriuretic Agents | 1 | 2010 | 1 | 0.080 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 155 | 0.080 |
Why?
|
| Water-Electrolyte Balance | 1 | 2010 | 15 | 0.080 |
Why?
|
| Hyponatremia | 1 | 2010 | 11 | 0.080 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2011 | 190 | 0.080 |
Why?
|
| Brain Injuries | 1 | 2011 | 141 | 0.080 |
Why?
|
| Anticonvulsants | 1 | 2010 | 104 | 0.080 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2011 | 420 | 0.080 |
Why?
|
| Hypertension | 2 | 2012 | 618 | 0.080 |
Why?
|
| Recurrence | 1 | 2011 | 665 | 0.080 |
Why?
|
| Disease Progression | 3 | 2010 | 1231 | 0.080 |
Why?
|
| Blood Urea Nitrogen | 1 | 2009 | 9 | 0.070 |
Why?
|
| Length of Stay | 1 | 2013 | 829 | 0.070 |
Why?
|
| Reflex, Pupillary | 1 | 2009 | 2 | 0.070 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2009 | 5 | 0.070 |
Why?
|
| Gait Disorders, Neurologic | 1 | 2009 | 17 | 0.070 |
Why?
|
| Confusion | 1 | 2009 | 16 | 0.070 |
Why?
|
| Ataxia | 1 | 2009 | 20 | 0.070 |
Why?
|
| Mesencephalon | 1 | 2009 | 28 | 0.070 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2011 | 312 | 0.070 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2011 | 214 | 0.070 |
Why?
|
| Rupture, Spontaneous | 1 | 2009 | 22 | 0.070 |
Why?
|
| Proportional Hazards Models | 1 | 2011 | 746 | 0.070 |
Why?
|
| Blood Pressure | 1 | 2011 | 537 | 0.070 |
Why?
|
| Surgical Instruments | 1 | 2009 | 44 | 0.070 |
Why?
|
| Prostheses and Implants | 1 | 2009 | 71 | 0.070 |
Why?
|
| Observer Variation | 1 | 2008 | 217 | 0.070 |
Why?
|
| Dexamethasone | 1 | 2009 | 214 | 0.070 |
Why?
|
| Apnea | 1 | 2008 | 33 | 0.070 |
Why?
|
| Cognition Disorders | 1 | 2009 | 224 | 0.070 |
Why?
|
| Comorbidity | 1 | 2011 | 1122 | 0.070 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2009 | 169 | 0.070 |
Why?
|
| Magnetic Resonance Angiography | 1 | 2008 | 202 | 0.060 |
Why?
|
| Polymerase Chain Reaction | 1 | 2008 | 516 | 0.060 |
Why?
|
| Incidence | 1 | 2011 | 1434 | 0.060 |
Why?
|
| Blood Glucose | 1 | 2009 | 502 | 0.060 |
Why?
|
| Multivariate Analysis | 1 | 2008 | 932 | 0.060 |
Why?
|
| Postoperative Complications | 2 | 2013 | 1335 | 0.060 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 274 | 0.060 |
Why?
|
| Insulin | 1 | 2009 | 695 | 0.060 |
Why?
|
| Atrial Fibrillation | 1 | 2013 | 885 | 0.050 |
Why?
|
| Clonidine | 1 | 2024 | 25 | 0.050 |
Why?
|
| Amines | 1 | 2024 | 31 | 0.050 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2024 | 77 | 0.050 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 1570 | 0.050 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 2500 | 0.050 |
Why?
|
| Checklist | 1 | 2022 | 72 | 0.040 |
Why?
|
| Glasgow Coma Scale | 2 | 2012 | 48 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2008 | 2116 | 0.040 |
Why?
|
| Tissue Donors | 1 | 2022 | 147 | 0.040 |
Why?
|
| Blood Chemical Analysis | 1 | 2021 | 20 | 0.040 |
Why?
|
| Living Donors | 1 | 2021 | 78 | 0.040 |
Why?
|
| Graft Survival | 1 | 2022 | 300 | 0.040 |
Why?
|
| Alcoholism | 1 | 2024 | 329 | 0.040 |
Why?
|
| Emergencies | 1 | 2021 | 124 | 0.040 |
Why?
|
| Herpesvirus 4, Human | 1 | 2021 | 199 | 0.040 |
Why?
|
| Animals | 1 | 2018 | 21494 | 0.040 |
Why?
|
| Age Factors | 1 | 2022 | 1595 | 0.030 |
Why?
|
| Iodine | 1 | 2017 | 21 | 0.030 |
Why?
|
| Stents | 1 | 2021 | 501 | 0.030 |
Why?
|
| Calibration | 1 | 2017 | 69 | 0.030 |
Why?
|
| Adolescent | 2 | 2021 | 6371 | 0.030 |
Why?
|
| Phantoms, Imaging | 1 | 2017 | 242 | 0.030 |
Why?
|
| Hospitalization | 1 | 2022 | 1404 | 0.030 |
Why?
|
| Physicians | 1 | 2021 | 487 | 0.030 |
Why?
|
| Sensitivity and Specificity | 1 | 2017 | 1172 | 0.030 |
Why?
|
| Software | 1 | 2017 | 401 | 0.030 |
Why?
|
| Vagus Nerve | 1 | 2013 | 20 | 0.020 |
Why?
|
| Telemetry | 1 | 2013 | 17 | 0.020 |
Why?
|
| Electrocardiography, Ambulatory | 1 | 2013 | 46 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2021 | 2790 | 0.020 |
Why?
|
| Hematoma, Subdural, Intracranial | 1 | 2011 | 2 | 0.020 |
Why?
|
| Mannitol | 1 | 2011 | 15 | 0.020 |
Why?
|
| APACHE | 1 | 2011 | 42 | 0.020 |
Why?
|
| Ventriculostomy | 1 | 2011 | 4 | 0.020 |
Why?
|
| Glasgow Outcome Scale | 1 | 2011 | 17 | 0.020 |
Why?
|
| Intracranial Pressure | 1 | 2011 | 19 | 0.020 |
Why?
|
| Drainage | 1 | 2012 | 153 | 0.020 |
Why?
|
| Interdisciplinary Communication | 1 | 2011 | 106 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 376 | 0.020 |
Why?
|
| Postpartum Period | 1 | 2012 | 190 | 0.020 |
Why?
|
| Trauma Centers | 1 | 2011 | 130 | 0.020 |
Why?
|
| Accidents, Traffic | 1 | 2011 | 140 | 0.020 |
Why?
|
| Hypovolemia | 1 | 2010 | 17 | 0.020 |
Why?
|
| Renin-Angiotensin System | 1 | 2010 | 22 | 0.020 |
Why?
|
| Natriuretic Peptides | 1 | 2010 | 9 | 0.020 |
Why?
|
| Case-Control Studies | 1 | 2013 | 1150 | 0.020 |
Why?
|
| Radiography | 1 | 2012 | 559 | 0.020 |
Why?
|
| Sympathetic Nervous System | 1 | 2010 | 35 | 0.020 |
Why?
|
| Cooperative Behavior | 1 | 2011 | 230 | 0.020 |
Why?
|
| Drug Administration Schedule | 1 | 2010 | 296 | 0.020 |
Why?
|
| Cerebellum | 1 | 2010 | 94 | 0.020 |
Why?
|
| Fatal Outcome | 1 | 2010 | 122 | 0.020 |
Why?
|
| Activities of Daily Living | 1 | 2011 | 295 | 0.020 |
Why?
|
| Vascular Surgical Procedures | 1 | 2012 | 240 | 0.020 |
Why?
|
| Necrosis | 1 | 2010 | 147 | 0.020 |
Why?
|
| United States | 1 | 2022 | 8192 | 0.020 |
Why?
|
| Kidney | 1 | 2010 | 460 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2010 | 993 | 0.020 |
Why?
|
| Critical Illness | 1 | 2010 | 342 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2013 | 3340 | 0.010 |
Why?
|
| Pregnancy | 1 | 2012 | 2411 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2010 | 2090 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2008 | 1441 | 0.010 |
Why?
|
| Young Adult | 1 | 2010 | 4887 | 0.010 |
Why?
|